CNBC-TV18 Investment Guide: Nifty Pharma up 40% in 2020; is there more steam to rally? Here's what experts say

CNBC-TV18's Investment Guide is a brand new weekly classroom series, where we join viewers in their investment journey with some enriching lessons from veterans of the stock market.

In the latest episode, Sonia Shenoy and Anuj Singhal get in conversation with Sailesh Raj Bhan, Deputy CIO of Equity Investments at Nippon India Mutual Fund and Nithya Balasubramanian, Director at Sanford Bernstein to discuss the pharma sector, which has seen a stupendous rally in 2020.

The Pharma Index has been an outperformer this year with 40 percent returns so far and a massive 81 percent return from 52 week low levels. It was a COVID-19 triggered rally, pharma being an essential, saw lesser disruption than other sectors and exposure to exports helped the business. Most of the pharma companies reported numbers better than expectations. Additionally, the China disruption and the new performance linked incentive increased the API sourcing from Indian companies.